Healthcare
Morning Movers: Market Trends and Stocks to Watch
Stay Ahead of the Curve with Today's Top Market Insights and Key Stock Performances Koninklije Philips N.V (PHG) Philips announces...
FDA Approves Pfizer’s Beqvez Gene Therapy for Hemophilia B: A Milestone in Rare Disease Treatment
Pfizer's Breakthrough Therapy Offers Hope to Patients Despite Hefty Price Tag The Food and Drug Administration's approval of Pfizer's (PFE)...
Biodexa’s Acquisition of eRapa Marks Milestone in FAP Treatment Development
Strategic Agreement with Emtora Biosciences Propels Biodexa's Oncology Pipeline Forward with Potential to Transform Treatment Landscape Biodexa Pharmaceuticals PLC (BDRX)...
Merck’s Strong First Quarter Performance Sets Positive Tone Amidst Patent Expiration Preparations
Keytruda Sales Surge and Vaccine Demand Drive Revenue Growth, Signaling Resilience Amidst Looming Challenges Merck (MRK), the pharmaceutical giant, kicked...
INVO Bioscience Reports Strong Revenue Growth in Q4 2023
Fertility Company Achieves Significant Expansion in Clinic Revenue INVO Bioscience (INVO) has released its financial results for the fourth quarter...
Vanda Pharmaceuticals Rejects Unsolicited Acquisition Proposals from Future Pak
Board Determines Offers Undervalue Company's Robust Growth Prospects Vanda Pharmaceuticals (VNDA) has confirmed receiving multiple unsolicited acquisition proposals from Future...
Palisade Bio Reports Promising Results for UC Treatment PALI-2108
Successful Analysis Demonstrates Effective Bioactivation of Colon-Specific PDE4 Inhibitor Prodrug Palisade Bio (PALI), a biopharmaceutical firm dedicated to advancing therapies...
PaxMedica Completes Milestone for Suramin IV Formulation, Nears FDA Submission
Biopharmaceutical Company Advances Potential Treatment for Fatal Tropical Disease and Autism Spectrum Disorder PaxMedica (PXMD) has achieved a significant milestone...
Candel Therapeutics’ CAN-2409 Receives FDA Orphan Drug Designation for Pancreatic Cancer
Milestone Achievement Enhances Development Efforts for Multimodal Biological Immunotherapy Candel Therapeutics (CADL) has achieved a significant milestone in its fight...
Rallybio Collaborates with Johnson & Johnson to Tackle Rare Disease FNAIT
Partnership Aims to Develop Therapeutic Solutions for Fetal and Neonatal Alloimmune Thrombocytopenia Rallybio Corporation (RLYB) has announced a collaboration with...
